Blog dermatologico
Elenco degli articoli nella categoria «Ricerca»
2020
Cutaneous adverse reactions to anti–PD-1 treatment. A systematic review
RicercaA systematic review...
Leggi tutto2020
Expanding treatment options for rosacea
RicercaSuch a high-quality cluster randomized controlled trial involving 2040 nurses across the UK....
Leggi tutto2020
2020
Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach
RicercaWith biologic drugs dominating the therapeutic space for severe immune‐mediated inflammatory disease, it is critical for clinicians to be familiar with the concept of drug immunogenicity, with the potential for our patients to develo...
Leggi tutto2020
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
RicercaDupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)...
Leggi tutto2020
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
RicercaIs exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?...
Leggi tutto2020
No increased risk of melanoma among patients with psoriasis treated with methotrexate
RicercaPatients with an impaired immune system have higher risk for melanoma, the most dangerous type of skin cancer, and a worse prognosis....
Leggi tutto2020
New jak inhibitors for the treatment of psoriasis and psoriatic arthritis
RicercaPsoriasis is a common inflammatory skin disease that can be associated with various pathological conditions among which arthritis is a frequent comorbidity....
Leggi tutto2020
A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy
RicercaAtypical network encompasses several patterns....
Leggi tutto2020
2020
Systematic Review of Mohs Micrographic Surgery in Children
RicercaIdentifying Challenges and Practical Considerations for Successful Application...
Leggi tutto2020
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice?
RicercaA prospective observational study...
Leggi tutto2020
An Overview of Uncommon Cutaneous Malignancies, Including Skin Appendageal (Adnexal) Tumours and Sarcomas
RicercaThe review is based on a search of peer-reviewed publications found using PubMed search tools and including the keywords identified above. In addition, the reference lists from other key articles were used to obtain other pertinent art...
Leggi tutto2020
Photosensitivity and cancer immune-targeted therapies
Ricercaadverse drug reaction, cancer, immune therapy, photoallergic, photosensitivity, phototoxic, reaction...
Leggi tutto2020
Overview on the treatment of Lyme disease in pregnancy
RicercaLyme disease is a tick-borne illness, which is typically caused by Borrelia Burgdoferi...
Leggi tutto2020
Tuscan Consensus on the diagnosis, treatment and follow up of adult atopic dermatitis
RicercaAtopic dermatitis (AD) is an inflammatory disease with a chronic-relapsing course that is intensely itchy....
Leggi tutto2020
Technological advances for the detection of melanoma
RicercaAdvances in diagnostic techniques...
Leggi tutto2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology
RicercaPemphigus encompasses a group of life‐threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin....
Leggi tutto2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
RicercaVitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life....
Leggi tutto2020
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab
RicercaIs the risk of severe cardiovascular events increased after the initiation of treatment with the anti–interleukin 12/23p40 (IL-12/23p40) monoclonal antibody ustekinumab?...
Leggi tutto